Surgical & Medical Instruments & Apparatus
Standard Industrial Classification: SIC 3841
Industry Insider Sentiment Analysis
The Surgical & Medical Instruments & Apparatus sector (SIC 3841) acts as a critical barometer for broader economic health. Our real-time monitoring reveals total transactions. Monitoring "cluster buying" is one of the most reliable leading indicators for future sector performance. By analyzing aggregate data across this specific Standard Industrial Classification, investors can filter out individual company volatility and identify high-conviction trends. When multiple directors and officers within the same industry move capital simultaneously, it often signals an upcoming sector-wide revaluation or a fundamental shift in supply chain dynamics that has yet to be recognized by the broader public market.
| Filing Date | Trade Date | Ticker | Company | Reporting Person | Relationship | Type | Price | Qty | Total, $ | Owned After |
|---|---|---|---|---|---|---|---|---|---|---|
| 2022-10-26 23:35 | 2022-10-24 | HAE | HAEMONETICS CORP | Basil Michelle L | Officer | SELL | $80.39 | 180 | $14,470 | 32,455 |
| 2022-10-26 23:43 | 2022-10-24 | HAE | HAEMONETICS CORP | Strong Stewart W | Officer | SELL | $80.39 | 75 | $6,029 | 15,681 |
| 2022-10-21 23:05 | 2022-10-19 | MCAGU | Mountain Crest Acquisition Corp. V | Mountain Crest Global Holdings LLC | 10% owner | SELL | $10.00 | 100,000 | $1,000,000 | 1,840,800 |
| 2022-10-21 23:05 | 2022-10-19 | MCAGU | Mountain Crest Acquisition Corp. V | Liu Suying | Director, Officer, 10% owner | SELL | $10.00 | 100,000 | $1,000,000 | 1,840,800 |
| 2022-10-22 03:00 | 2022-10-19 | TMCI | TREACE MEDICAL CONCEPTS, INC. | TREACE JAMES T | Director | SELL | $22.84 | 50,000 | $1,141,820 | 1,086,441 |
| 2022-10-20 23:19 | 2022-10-18 | XTNT | Xtant Medical Holdings, Inc. | Browne Sean E | Director, Officer | SELL | $0.65 | 131,100 | $85,831 | 1,506,584 |
| 2022-10-21 01:39 | 2022-10-18 | TMCI | TREACE MEDICAL CONCEPTS, INC. | BAYS F BARRY | Director | SELL | $23.37 | 51,690 | $1,208,192 | 1,563,937 |
| 2022-10-18 23:27 | 2022-10-17 | BSX | BOSTON SCIENTIFIC CORP | Carruthers Wendy | Officer | SELL | $40.52 | 13,322 | $539,743 | 96,591 |
| 2022-10-18 23:18 | 2022-10-17 | RMD | RESMED INC | Farrell Michael J. | Officer | OPT+S | $214.58 | 5,675 | $1,217,723 | 422,570 |
| 2022-10-19 04:10 | 2022-10-17 | SIBN | SI-BONE, Inc. | Pisetsky Michael A | Officer | SELL | $18.39 | 355 | $6,527 | 119,539 |
| 2022-10-19 04:11 | 2022-10-17 | SIBN | SI-BONE, Inc. | RECUPERO ANTHONY J | Officer | SELL | $18.52 | 587 | $10,872 | 168,676 |
| 2022-10-19 04:12 | 2022-10-17 | SIBN | SI-BONE, Inc. | DUNN JEFFREY W | Director | SELL | $18.34 | 2,114 | $38,772 | 113,842 |
| 2022-10-17 23:35 | 2022-10-13 | NVCR | NovoCure Ltd | Leonard Frank X | Officer | SELL | $76.01 | 6,754 | $513,372 | 43,626 |
| 2022-10-18 02:25 | 2022-10-14 | RMD | RESMED INC | Douglas Robert Andrew | Officer | OPT+S | $215.09 | 11,355 | $2,442,298 | 35,086 |
| 2022-10-13 00:23 | 2022-10-12 | ANGO | Angiodynamics Inc. | Trowbridge Stephen A | Officer | BUY | $13.82 | 1,083 | $14,967 | 89,581 |
| 2022-10-12 23:25 | 2022-10-11 | STIM | Neuronetics, Inc. | Furlong Stephen | Officer | SELL | $2.97 | 1,630 | $4,841 | 389,319 |
| 2022-10-12 02:11 | 2022-10-07 | PLSE | PULSE BIOSCIENCES, INC. | Levinson Mitchell E. | Director, Officer | BUY | $2.27 | 30,780 | $69,908 | 5,034 |
| 2022-10-12 02:29 | 2022-10-11 | TELA | TELA Bio, Inc. | Opaleye Management Inc. | 10% owner | BUY | $8.00 | 16,000 | $128,000 | 123,551 |
| 2022-10-11 23:48 | 2022-10-07 | XTNT | Xtant Medical Holdings, Inc. | Vizirgianakis Stavros G. | Director | BUY | $0.48 | 2,264,861 | $1,087,133 | 5,850,716 |
| 2022-10-11 23:06 | 2022-10-10 | ANGO | Angiodynamics Inc. | Clemmer James C | Director, Officer | BUY | $15.00 | 10,000 | $150,000 | 450,407 |
| 2022-10-12 00:33 | 2022-10-07 | STIM | Neuronetics, Inc. | MACAN WILLIAM ANDREW | Officer | SELL | $2.92 | 1,623 | $4,747 | 354,765 |
| 2022-10-07 23:16 | 2022-10-06 | NVCR | NovoCure Ltd | Leonard Frank X | Officer | SELL | $84.37 | 6,754 | $569,835 | 50,380 |
| 2022-10-08 01:01 | 2022-10-05 | TMCI | TREACE MEDICAL CONCEPTS, INC. | BAYS F BARRY | Director | SELL | $22.85 | 29,774 | $680,324 | 1,615,627 |
| 2022-10-06 03:37 | 2022-10-03 | PEN | Penumbra Inc | Roberts Johanna | Officer | OPT+S | $193.02 | 1,500 | $289,537 | 55,496 |
| 2022-10-06 03:34 | 2022-10-03 | PEN | Penumbra Inc | Wilder Thomas | Director | SELL | $191.20 | 124 | $23,709 | 338 |
| 2022-10-06 03:32 | 2022-10-03 | PEN | Penumbra Inc | Sarna Surbhi | Director | SELL | $191.20 | 28 | $5,354 | 1,952 |
| 2022-10-06 03:31 | 2022-10-03 | PEN | Penumbra Inc | O'Rourke Bridget | Director | SELL | $191.20 | 88 | $16,826 | 3,784 |
| 2022-10-05 18:35 | 2022-10-03 | RMD | RESMED INC | PENDARVIS DAVID | Officer | SELL | $220.19 | 1,545 | $340,194 | 103,879 |
| 2022-10-04 23:28 | 2022-10-03 | BSX | BOSTON SCIENTIFIC CORP | Mahoney Michael F | Director, Officer | OPT+S | $39.34 | 125,827 | $4,949,556 | 1,767,665 |
| 2022-10-04 23:28 | 2022-10-03 | PODD | INSULET CORP | Petrovic Shacey | Director | OPT+S | $231.80 | 15,000 | $3,477,000 | 13,695 |
| 2022-10-04 23:49 | 2022-10-03 | ARAY | Accuray Incorporated | Hoge Michael | Officer | SELL | $2.10 | 8,324 | $17,470 | 291,904 |
| 2022-10-04 23:49 | 2022-10-03 | ARAY | Accuray Incorporated | Winter Suzanne C | Officer | SELL | $2.10 | 17,060 | $35,806 | 769,596 |
| 2022-10-04 23:52 | 2022-10-03 | ARAY | Accuray Incorporated | Chew Jesse | Officer | SELL | $2.10 | 8,995 | $18,879 | 259,046 |
| 2022-10-04 23:48 | 2022-10-03 | ARAY | Accuray Incorporated | Spine Patrick | Officer | SELL | $2.10 | 5,843 | $12,263 | 219,251 |
| 2022-10-03 23:35 | 2022-09-30 | PLSE | PULSE BIOSCIENCES, INC. | Danahy Kevin Patrick | Officer | BUY | $2.30 | 6,500 | $14,950 | 6,500 |
| 2022-10-04 00:43 | 2022-09-27 | ATAO | Premier Air Charter Holdings Inc. | Lovallo Leonard | Director, Officer | SELL | $0.02 | 150,000 | $2,595 | 38,405,000 |
| 2022-09-30 23:20 | 2022-09-29 | NVCR | NovoCure Ltd | Leonard Frank X | Officer | SELL | $77.35 | 6,754 | $522,422 | 57,134 |
| 2022-10-01 04:31 | 2022-09-29 | IRTC | iRhythm Holdings, Inc. | Devine Douglas | Officer | SELL | $125.00 | 2,000 | $250,000 | 27,702 |
| 2022-09-30 01:00 | 2022-09-27 | TMCI | TREACE MEDICAL CONCEPTS, INC. | BAYS F BARRY | Director | SELL | $22.77 | 37,492 | $853,700 | 1,645,401 |
| 2022-09-28 18:05 | 2022-09-26 | IRTC | iRhythm Holdings, Inc. | Wilson Daniel G. | Officer | SELL | $122.57 | 3,000 | $367,716 | 34,562 |
| 2022-09-26 23:19 | 2022-09-22 | NVCR | NovoCure Ltd | Leonard Frank X | Officer | SELL | $77.00 | 6,754 | $520,058 | 63,888 |
| 2022-09-26 23:05 | 2022-09-23 | TELA | TELA Bio, Inc. | Opaleye Management Inc. | 10% owner | BUY | $7.99 | 6,804 | $54,393 | 122,551 |
| 2022-09-22 18:46 | 2022-09-20 | LUCD | Lucid Diagnostics Inc. | Lapidus Stanley | Director | SELL | $1.70 | 33,864 | $57,684 | 135,456 |
| 2022-09-21 23:42 | 2022-09-19 | HAE | HAEMONETICS CORP | Miller Laurie A. | Officer | SELL | $76.25 | 212 | $16,165 | 12,697 |
| 2022-09-21 23:50 | 2022-09-19 | HAE | HAEMONETICS CORP | Basil Michelle L | Officer | OPT+S | $78.36 | 11,448 | $897,065 | 32,635 |
| 2022-09-19 23:39 | 2022-09-15 | HAE | HAEMONETICS CORP | Basil Michelle L | Officer | OPT+S | $77.89 | 33,798 | $2,632,594 | 35,395 |
| 2022-09-19 23:10 | 2022-09-15 | NVCR | NovoCure Ltd | Leonard Frank X | Officer | OPT+S | $88.52 | 12,271 | $1,086,222 | 70,642 |
| 2022-09-20 02:27 | 2022-09-19 | TELA | TELA Bio, Inc. | Opaleye Management Inc. | 10% owner | BUY | $8.09 | 18,000 | $145,584 | 122,247 |
| 2022-09-19 19:19 | 2022-09-15 | RMD | RESMED INC | Farrell Michael J. | Officer | OPT+S | $228.96 | 5,675 | $1,299,336 | 422,570 |
| 2022-09-20 00:00 | 2022-09-16 | VERO | Venus Concept Inc. | Della Penna Domenic | Officer | BUY | $0.59 | 60,000 | $35,400 | 126,663 |
Sector-Wide Insider Alpha
Analyzing insider movements across the Surgical & Medical Instruments & Apparatus sector provides a macro-view of executive conviction. When multiple leaders in different companies within the same SIC code (3841) simultaneously buy shares, it often indicates an industry-wide undervaluation or a positive shift in market cycles.
SEC Filings in Surgical & Medical Instruments & Apparatus
Every transaction in the Surgical & Medical Instruments & Apparatus industry is reported via Form 4 disclosures. By filtering these filings by industry, investors can detect institutional-scale sentiment shifts before they are reflected in broader market indices, following the capital flow of those with intimate industry knowledge.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.